Sinopharm BBIBP-CorV COVID-19 allurar rigakafin cuta ce da aka yi ta daga ƙwayoyin ƙwayoyin cuta waɗanda ba su da ikon kamuwa da cuta. Sinopharm Holdings da Cibiyar Nazarin Halittu ta Beijing ne suka haɓaka wannan ɗan takarar rigakafin.